Overview of Dr. Diaz
Dr. Luis Diaz is an oncologist in New York, NY and is affiliated with multiple hospitals in the area, including Memorial Sloan Kettering Cancer Center and Memorial Hospital for Cancer and allied Diseases. He received his medical degree from University of Michigan Medical School and has been in practice 19 years. Dr. Diaz accepts several types of health insurance, listed below. He is one of 495 doctors at Memorial Sloan Kettering Cancer Center and one of 90 doctors at Memorial Hospital for Cancer and allied Diseases who specialize in Oncology. He also speaks multiple languages, including Spanish. He has more than 100 publications and over 500 citings.
Office
1275 York Avenue
New York, NY 10065
Education & Training
Johns Hopkins UniversityFellowship, Hematology and Medical Oncology, 2001 - 2004- Johns Hopkins UniversityResidency, Internal Medicine, 1998 - 2001
University of Michigan Medical SchoolClass of 1998
Certifications & Licensure
MD State Medical License 2001 - 2026
NY State Medical License 2017 - 2026
NJ State Medical License 2019 - 2025
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2014
Clinical Trials
- One Time Injection of Bacteria to Treat Solid Tumors That Have Not Responded to Standard Therapy Start of enrollment: 2006 Jul 01
- QUILT-3.019: Phase 2 Study of NPC-1C Chimeric Monoclonal Antibody to Treat Pancreatic and Colorectal Cancer Start of enrollment: 2012 Jan 01
- Palliative Stereotactic Radiation for Pancreatic or Periampullary Adenocarcinoma Start of enrollment: 2013 Jan 01
- Join now to see all
Publications & Presentations
PubMed
- 51 citationsTakotsubo Cardiomyopathy and Fluorouracil: Case Report and Review of the LiteratureMichael R. Grunwald, Lynn Howie, Luis A. Diaz
Journal of Clinical Oncology. 2012-01-10 - 1439 citationsFulminant Myocarditis with Combination Immune Checkpoint BlockadeDouglas B. Johnson, Justin M. Balko, Margaret L. Compton, Spyridon Chalkias, Joshua M. Gorham
The New England Journal of Medicine. 2016-11-02 - 404 citationsEradication of metastatic mouse cancers resistant to immune checkpoint blockade by suppression of myeloid-derived cells.Kibem Kim, Andrew D. Skora, Zhaobo Li, Liu Qiang, Ada J. Tam
Proceedings of the National Academy of Sciences of the United States of America. 2014-08-12
Journal Articles
- Pembrolizumab in Microsatellite-Instability–High Advanced Colorectal CancerJohanna Bendell, Luis A Diaz, The New England Journal of Medicine
Press Mentions
Groundbreaking Clinical Trial Achieves 100% Remission Rate for All Cancer PatientsOctober 18th, 2024- Incredible Cancer Trial Achieves a 100% Remission Rate for All PatientsSeptember 11th, 2024
- Clinical Trial Results in an Incredible 100% Remission Rate for All Participating Cancer PatientsAugust 10th, 2024
- Join now to see all
Professional Memberships
- Member
Other Languages
- Spanish
External Links
- Johns Hopkins Physicianshttp://www.hopkinsmedicine.org/luis-diaz
Insurance Accepted
- BCBS Blue Card PPO
CareFirst BlueChoice Advantage
CareFirst BlueChoice Network POS
CareFirst BluePreferred PPO
CIGNA HMO
CIGNA Open Access
CIGNA PPOGreat West PPO
Humana ChoiceCare Network PPO
Multiplan PHCS PPO
Multiplan PPO
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO - Please verify your coverage with the provider's office directly when scheduling an appointment
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
